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Foodborne pathogenic E. coli continue to emerge and evolve as significant human pathogens. With cattle and other ruminants acting as natural reservoirs, they contaminate food directly via contamination of animals at slaughter or indirectly via the use of contaminated manure or water during food production. E. coli O157 remains the predominant disease causing serotype although additional serotypes such as O26 and O111, along with E. coli possessing novel combinations of virulence genes, highlight the increasing complexity associated with reducing the prevalence of foodborne pathogenic E. coli. Variability in the severity of disease caused by different E. coli provides insight into the significance of virulence factors thereby enabling the design of possible control methods such as vaccines. The continuing burden of foodborne pathogenic E. coli presents a challenge for food producers and researchers to overcome to ensure an ongoing supply of safe and healthy food.
What is STEC?
Escherichia coli is a member of the gut microbiome of the majority of warm blooded animals, including humans. E. coli generally exist harmlessly within the gut performing physiological activities that benefit themselves, their host, and the associated microbiome.
However, E. coli is perhaps most well known for its ability to cause disease in humans. Shiga toxin-producing E. coli (STEC) were first identified as a foodborne pathogen in 1982 and are characterised by the ability to produce Shiga toxin 1 . STEC are an important public health concern as they have caused large foodborne outbreaks, are particularly dangerous to small children where acute renal failure is often observed, which can sometimes lead to death.
How does E. coli become pathogenic? revealed that non-O157 serotypes were substantial contributors to the overall incidence of STEC-associated infections observed in the Australian health system (Figure 3  7 ). In the USA, STEC surveillance data analysis determined that the ratio of non-O157 to O157 infections is approaching two to one with 63,000 E. coli O157 and 110,000 non-O157 infections estimated to occur annually 8 . Although the occurrence of serious diseases and death remains more common with E. coli O157 infections than with non-O157, the burden of non-O157 infections on health systems is evident. As surveillance and methods for non-O157 isolation improve we can expect greater implication of non-O157 STEC in outbreaks and sporadic cases of human disease.
In addition to the materialisation of non-O157 STEC serotypes as major human pathogens, 2011 saw the emergence of a novel pathotype of E. coli that was ultimately responsible for the most devastating E. coli outbreak to date. The three month long outbreak was caused by a hybrid E. coli of serotype O104:H4 that harbored virulence traits common to STEC as well as enteroaggregative E. coli. A total of 4321 cases were recorded with 852 cases How can we prevent contaminated foods entering commerce?
There are generally two ways we can prevent foods contaminated with pathogenic E. coli from entering commerce: put hurdles in place to restrict food becoming contaminated or find ways to As our understanding of microbiological pathogens and their interaction with hosts expands, the complexity of assessing the risks posed by these hazards is also increasing. This is compounded by the extension of food production pathways, with multiple processes and/or new technologies used to produce the food that consumers desire. While based on principles developed for assessing toxicological and carcinogenic hazards, microbiological risk assessment throws up many challenges due to the ability of some microorganisms (bacteria) to multiply, or become inactivated, as food moves through the production to consumption continuum.
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